Strides Pharma Science Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

92.16

91.90

90.30

89.79

89.68

Share application money

-

2.97

2.32

2.45

4.72

Preference share capital

-

-

-

-

-

Reserves & surplus

3,100.57

3,466.25

3,362.43

3,314.44

3,153.66

Loan funds

Secured loans

1,156.25

1,594.18

1,349.20

1,244.63

841.04

Unsecured loans

-

-

-

-

-

Total

4,348.99

5,155.30

4,804.26

4,651.32

4,089.10

Uses of funds

Fixed assets

Gross block

1,373.96

1,115.61

1,058.56

1,042.53

999.08

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

607.02

559.42

462.00

425.62

354.59

Net block

766.94

556.20

596.56

616.91

644.49

Capital work-in-progress

105.68

94.01

55.38

55.72

110.67

Investments

1,847.69

2,498.34

2,491.77

2,399.76

2,394.65

Net current assets

Current assets, loans & advances

2,310.65

2,689.25

2,476.03

2,361.47

2,071.52

Less : current liabilities & provisions

681.96

682.48

815.49

782.54

1,132.24

Total net current assets

1,628.69

2,006.77

1,660.55

1,578.93

939.29

Miscellaneous expenses not written

-

-

-

-

-

Total

4,348.99

5,155.30

4,804.26

4,651.32

4,089.10

Notes:

Book value of unquoted investments

1,847.69

-

-

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

301.43

816.95

632.08

2,345.08

1,929.34

Number of equity sharesoutstanding (Lacs)

921.63

919.00

903.03

897.90

896.81